Subcutaneous fat necrosis (SFN) of the newborn is an uncommon disorder of the adipose tissue, mostly affecting full-term or post-term newborns who experience perinatal distress. The lesions of SFN typically occur during the first six weeks of life; they are usually self-limited and no specific therapy is required. The disorder may be rarely complicated with hypercalcaemia. We present the case of a neonate with perinatal asphyxia who manifested SFN followed by hypocalcaemia instead of hypercalcaemia and a biochemical profile of pseudohypoparathyroidism four weeks after the eruption of skin lesions. The infant was treated with alfacalcidiol. Blood biochemistry was normalized within one week and serum parathyroid hormone levels declined to normal over the next two months. It is suggested that perinatal asphyxia was the common etiopathogenetic factor for the development of both SFN and pseudohypoparathyroidism.
Introduction
Subcutaneous fat necrosis (SFN) is an inflammatory disorder of the adipose tissue, which predominantly affects healthy full-or post-term neonates with a history of perinatal stress. It usually appears during the first 6 weeks of life; however, the onset may be delayed up to months after birth. The skin lesions are usually located on the buttocks, cheeks, posterior trunk, arms and legs, with sparing of the anterior trunk. [1] [2] [3] Typically they appear as firm, well circumscribed subcutaneous nodules or plaques which are colorless, red or haemorrhagic and may be extremely painful at palpation during the acute phase of inflammation. In the majority of cases the lesions are self-limited and resolve spontaneously within 2-4 weeks without atrophy or scarring; thus, no specific therapy is required. In few cases, SFN may be complicated with hypercalcaemia, which usually develops 1-6 weeks after the eruption of the lesions or even later, after the complete resolution of the lesions. [4] [5] [6] We report the case of a neonate with SFN who developed hypocalcaemia instead of hypercalcaemia.
Case report
A female full-term neonate was admitted to our unit at the first day of life. She was delivered by emergency cesarean section due to fetal distress. The pregnancy was uncomplicated up to delivery. The birth weight was 2500 g (3rd centile), the body length was 47 cm (10th centile) and the head circumference was 33 cm (10th centile). Apgar scores were 2, 3 and 8 at 1, 5 and 10 min, respectively. The baby needed resuscitation and was placed on mechanical ventilation due to respiratory failure. The cord arterial pH was 6.9 and the base deficit was À14.7 mmol/l. Mechanical ventilation was discontinued 8 h later, and diffuse oxygen was supplied (FiO 2 up to 30%). On clinical examination the baby was hypotonic, tachypnoic (respiration rate 60/min.), with weak Moro and poor sucking reflex. Her blood pressure was 73/45 mmHg and the pulse rate was 142/min. A full blood count, blood biochemistry and serum C-reactive protein levels were all normal. Blood cultures were negative and a chest X-ray showed mild cardiac enlargement, but no lung pathology. Her oxygen requirements were attributed to persistent pulmonary hypertension following birth asphyxia. This was supported by an echocardiography, which revealed right to left shunting across the patent foramen ovale and ductus arteriosus. A cranial ultrasound was suggestive of mild cerebral oedema.
Oxygen was provided to the baby for the following five days of hospitalization, and she was fed by a nasogastric tube due to weak sucking. Her condition gradually improved. Finally, at day 16 of life the infant was in a good health, bottle fed and ready to discharge. However, the following day, some firm, circumscribed, subcutaneous, reddish, painful at palpation nodules, characteristic of SFN, were observed on her posterior trunk. The clinical diagnosis was confirmed by a skin biopsy and histological examination, which revealed fat necrosis, thickening of the connective tissue bands around the fat lobules, as well as granulomatous inflammatory reaction of lymphocytes, histiocytes and foreign body-type giant cells (Figure 1) .
During the first 3 weeks of the eruption of skin lesions, serum calcium, phosphorus and alkaline phosphatase levels were within the normal range on repeated biochemical analyses. However, at the fourth week, serum calcium concentrations gradually declined to 6.2 mg/dl (normal 8.8-10.8 mg/dl), while the phosphorus and alkaline phosphatase levels increased up to 7.2 mg/dl (normal 3.8-6.5 mg/dl) and 709 IU/l (normal 145-420 IU/l), respectively. Ionized calcium was low (3.76 mg/dl, normal 4.8-4.9 mg/dl), whereas total protein, albumin, electrolytes, magnesium, urea, creatine, transaminases and triglycerides levels in serum were all normal. The biochemical profile of hypoparathyroidism (hypocalcaemia, hyperphosphataemia and increased alkaline phosphatase) was repeatedly noticed; however serum parathyroid hormone (PTH) concentrations were high (245 pg/ml, normal 10-65 pg/ml), whereas those of 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D were in the normal range (52 nmol/l and 27 pg/ml, respectively; normal 25-150 nmol/l and 16-60 pg/ml, respectively). The above findings were consistent with pseudohypoparathyroidism. A wrist X-ray did not reveal any abnormality.
The baby was treated with alfacalcidiol (One-Alpha, 0.3 mg daily per os). Serum calcium and phosphorus levels returned to normal 1 week after the onset of treatment. Serum PTH and alkaline phosphatase levels gradually declined to 92.4 pg/ml and 465 IU/l, respectively, at the fourth week of treatment and they were fully normalized at the eighth week (at 3.5 months of age). The skin lesions had already resolved completely by 6 weeks after their eruption.
The baby was carefully followed up; repeat biochemical analysis including serum PTH levels were normal. Alfacalcidiol was discontinued at the sixth month of life. Now, at the age of 18 months, the baby has normal physical and neurological development with no pathological laboratory findings. Discussion SFN is a rare, benign, inflammatory disorder of the adipose tissue, which resolves spontaneously in a few weeks. Its exact prevalence and etiopathogenesis are yet unknown. Several aetiological factors have been associated with SFN, including factors related to perinatal stress such as perinatal asphyxia, obstetric trauma and hypothermia, and maternal factors such as pre-eclampsia and gestational diabetes. However, in many cases the past history of the patient is negative. 5, 7 Perinatal asphyxia was the only recognized predisposing factor in our patient.
It has been suggested that an underlying defect in fat composition or metabolism may play an important role in the development of SFN. In neonates, subcutaneous fat is mostly composed of saturated fatty acids (stearic and palmitic acids) as a result of the inadequately developed enzyme systems involved in fatty acid desaturation. Neonatal stress may exacerbate this enzymic defect, thus affecting the subcutaneous fat metabolism, leading to an increased fat composition in saturated fatty acids. In addition, with stress, neonatal subcutaneous fat may undergo crystallization due to the high melting point (641C) of the saturated fatty acids. This process may lead to adipocyte damage and granulomatous reaction to the resultant fat necrosis. 7 Hypercalcaemia is a rare complication of SFN with a high mortality rate up to 15%. Its pathogenesis remains obscure while possible mechanisms include enhanced bone resorption (as a result of prostaglandin E 2 action), increased vitamin D sensitivity, calcium release from calcified necrotic subcutaneous fat and, mainly, extrarenal unregulated production of calcitriol from the macrophages in the site of the granulomatous inflammatory process. [5] [6] [7] [8] [9] [10] Owing to the severe sequelae of hypercalcaemia, it is recommended that serum calcium levels be checked periodically in infants with SFN [4] [5] [6] as it was performed in the present case. Surprisingly, our infant presented hypocalcaemia and the laboratory findings were suggestive of pseudohypoparathyroidism. To our knowledge, no such complication of SFN has been reported so far. Whether perinatal asphyxia, a possible aetiologic factor for the development of SFN in our baby, is also causatively related to the presented pseudohypoparathyroidism, is not known. However, it is known that the action of PTH is mediated by specific receptor activation, resulting in stimulation of the intracellular signal transduction system of adenylate cyclase and phospholipase C. A disregulation in the function of PTH receptor and/or intracellular signal transduction systems may result in the development of pseudohypoparathyroidism. 11 It has been postulated that PTH receptor and its signal transduction system may be defective developmentally during the fetal and neonatal period of life and mature thereafter. 9, 10 Moreover, it has been reported that hypoxia causes hyporesponsiveness to parathyroid hormone action. 12, 13 Thus, it might be suggested that in our patient perinatal asphyxia exacerbated the functional immaturity of PTH receptor and/or signal transduction systems and resulted in the development of transient pseudohypoparathyroidism. 
